- Building a workforce engine for biomanufacturingOhio’s $30M training initiative aims to scale talent pipelines and power life sciences growth statewide.Fierce Biotech · 14d ago↗ source
- De-Risking a Rare Disease Launch Starts with PrecisionWhy traditional models fall short in rare disease commercialization—and what works instead.Fierce Biotech · 1mo ago↗ source
- <![CDATA[Dr Meeks on a Real-World Study of BCG Retreatment After BCG Failure in NMIBC]]><![CDATA[Joshua J. Meeks, MD, PhD, discusses data from a real-world study of BCG retreatment after BCG failure in NMIBC.]]>onclive · 2mo ago↗ source